These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 16469851

  • 1. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ, Tiddens HA, Verbrugh HA, Ott A.
    J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
    [Abstract] [Full Text] [Related]

  • 2. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR, Pressler T, Hoiby N, Johansen HK.
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [Abstract] [Full Text] [Related]

  • 3. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA, Wolfs TF, Fleer A, Kimpen JL, van der Ent CK.
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [Abstract] [Full Text] [Related]

  • 4. Macrolide-resistant Staphylococcus aureus colonization in cystic fibrosis patients: is there transmission to household contacts?
    Tramper-Stranders GA, van der Ent CK, Gerritsen SA, Fleer A, Kimpen JL, Wolfs TF.
    J Antimicrob Chemother; 2007 Sep; 60(3):665-8. PubMed ID: 17604321
    [Abstract] [Full Text] [Related]

  • 5. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A, Maeda Y, Goldsmith CE, Coulter WA, Mason C, Millar BC, McCalmont M, Rendall J, Elborn JS, Matsuda M, Moore JE.
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [Abstract] [Full Text] [Related]

  • 6. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients.
    Vergison A, Denis O, Deplano A, Casimir G, Claeys G, DeBaets F, DeBoeck K, Douat N, Franckx H, Gigi J, Ieven M, Knoop C, Lebeque P, Lebrun F, Malfroot A, Paucquay F, Pierard D, Van Eldere J, Struelens MJ.
    J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469
    [Abstract] [Full Text] [Related]

  • 7. Characterization of macrolide resistance genes in Haemophilus influenzae isolated from children with cystic fibrosis.
    Roberts MC, Soge OO, No DB.
    J Antimicrob Chemother; 2011 Jan; 66(1):100-4. PubMed ID: 21081549
    [Abstract] [Full Text] [Related]

  • 8. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics.
    Pirzada OM, McGaw J, Taylor CJ, Everard ML.
    J Cyst Fibros; 2003 Jun; 2(2):69-71. PubMed ID: 15463852
    [Abstract] [Full Text] [Related]

  • 9. [Drug susceptibility of Haemophilus sp. and Staphylococcus aureus strains colonizing respiratory tract in children with mucoviscidosis].
    Kosikowska U, Juda M, Malm A, Jóźwiakowska M, Tuszkiewicz-Misztal E.
    Przegl Epidemiol; 2007 Jun; 61(2):377-84. PubMed ID: 17956057
    [Abstract] [Full Text] [Related]

  • 10. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains.
    Prunier AL, Malbruny B, Laurans M, Brouard J, Duhamel JF, Leclercq R.
    J Infect Dis; 2003 Jun 01; 187(11):1709-16. PubMed ID: 12751028
    [Abstract] [Full Text] [Related]

  • 11. Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial.
    Kabra SK, Pawaiya R, Lodha R, Kapil A, Kabra M, Vani AS, Agarwal G, Shastri SS.
    J Cyst Fibros; 2010 Jan 01; 9(1):17-23. PubMed ID: 19818694
    [Abstract] [Full Text] [Related]

  • 12. High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation.
    Molina A, Del Campo R, Máiz L, Morosini MI, Lamas A, Baquero F, Cantón R.
    J Antimicrob Chemother; 2008 Nov 01; 62(5):961-7. PubMed ID: 18647744
    [Abstract] [Full Text] [Related]

  • 13. Long-term effects of azithromycin in patients with cystic fibrosis.
    Samson C, Tamalet A, Thien HV, Taytard J, Perisson C, Nathan N, Clement A, Boelle PY, Corvol H.
    Respir Med; 2016 Aug 01; 117():1-6. PubMed ID: 27492507
    [Abstract] [Full Text] [Related]

  • 14. Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005.
    Karlowsky JA, Lagacé-Wiens PR, Low DE, Zhanel GG.
    Int J Antimicrob Agents; 2009 Oct 01; 34(4):375-9. PubMed ID: 19560902
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
    Cantón R, Valdezate S, Vindel A, Sánchez Del Saz B, Maíz L, Baquero F.
    Pediatr Pulmonol; 2003 Feb 01; 35(2):99-107. PubMed ID: 12526070
    [Abstract] [Full Text] [Related]

  • 16. Characterization of Staphylococcus aureus Strains Isolated from Czech Cystic Fibrosis Patients: High Rate of Ribosomal Mutation Conferring Resistance to MLS(B) Antibiotics as a Result of Long-Term and Low-Dose Azithromycin Treatment.
    Tkadlec J, Vařeková E, Pantůček R, Doškař J, Růžičková V, Botka T, Fila L, Melter O.
    Microb Drug Resist; 2015 Aug 01; 21(4):416-23. PubMed ID: 25826283
    [Abstract] [Full Text] [Related]

  • 17. High phenotypic diversity in infecting but not in colonizing Staphylococcus aureus populations.
    Goerke C, Gressinger M, Endler K, Breitkopf C, Wardecki K, Stern M, Wolz C, Kahl BC.
    Environ Microbiol; 2007 Dec 01; 9(12):3134-42. PubMed ID: 17991040
    [Abstract] [Full Text] [Related]

  • 18. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
    Hansen CR, Pressler T, Koch C, Høiby N.
    J Cyst Fibros; 2005 Mar 01; 4(1):35-40. PubMed ID: 15752679
    [Abstract] [Full Text] [Related]

  • 19. [Isolated pathogen microorganisms in respiratory samples from children with cystic fibrosis].
    Anzaudo MM, Busquets NP, Ronchi S, Mayoral C.
    Rev Argent Microbiol; 2005 Mar 01; 37(3):129-34. PubMed ID: 16323660
    [Abstract] [Full Text] [Related]

  • 20. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
    Bosnar M, Kragol G, Koštrun S, Vujasinović I, Bošnjak B, Bencetić Mihaljević V, Marušić Ištuk Z, Kapić S, Hrvačić B, Brajša K, Tavčar B, Jelić D, Glojnarić I, Verbanac D, Culić O, Padovan J, Alihodžić S, Eraković Haber V, Spaventi R.
    J Med Chem; 2012 Jul 12; 55(13):6111-23. PubMed ID: 22697905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.